Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1969-1974

  Lilja, J F ^a   Wu, D ^a   Reynolds, R K ^a   Lin, J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

AKT; Endometrial cancer; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CYTOSKELETAL PROTEINS; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; PTEN PHOSPHOHYDROLASE; RATS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034910833     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abstract 2166: Introduction of the PTEN gene induces apoptosis in endometrial carcinoma
2. FIGO annual report on the results of treatment in gynaecological cancer
3. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
4. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
5. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
6. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
7. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
8. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer
9. Mechanism of activation of protein kinase B by insulin and IGF-1
10. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
11. The PI 3-kinase/Akt signaling pathway delivers an antiapoptotic signal
12. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt
13. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
14. Interleukin- 3-induced phosphorylation of BAD through the protein kinase Akt
15. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
16. Regulation of cell death protease caspase-9 by phosphorylation
17. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
18. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
19. PTEN/MMAC1 mutations in endometrial cancers
20. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
21. Cancer Res
22. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
23. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblasotma cells
24. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
25. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
26. Regulation of neuronal survival by the serine-threonine protein kinase AKT
27. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
28. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
29. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer
30. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes
31. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
32. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly
33. Beta-catenin is a target for the ubiquitin-proteasome pathway
34. A genetic model for colorectal tumorigenesis
35. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
36. Functional interaction of beta-catenin with the transcription factor LEF-1
37. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL
38. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways
39. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
40. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene
41. Studies on ras oncogene activation in endometrial carcinoma
42. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium
43. Mutations and amplification of oncogenes in endometrial cancer
44. Fluorescence in situ hybridization analysis of HER-2/neu, c-myc and p53 in endometrial cancer